Thank you.
When I did my investigative research, as it were.... Health Canada, as you may know, is undertaking some work right now to evaluate the drug review and approval process so that Canadians who need a wider variety of medications—or medical options, shall we say.... As part of this work, the government will be examining options for establishing a rebate program to retroactively reimburse Canadians an amount in recognition of the federal portion of the proposed excise duty that was imposed on equivalent products prior to their being given a drug identification number.
Health Canada is looking into—this is from them, not from me, if I might finish—the array of options, as we know, in terms of medical cannabis. A lot of things have changed in the last 10 or 15 years. It's looking at what products should have a drug identification number. If these products indeed do have a drug identification number through this process that's put in place, then Health Canada will look at what supports it can provide to those who were taking that drug prior to the identification.
Health Canada is looking into it. Maybe that's the place it should stay.